Current Insights on Treatment Adherence in Prevalent Dermatological Conditions and Strategies To Optimize Adherence Rates

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Oct 21

PMID 39429316

Authors

Nicoleta Cirstea

Ada Radu

Cosmin Vesa

Andrei Flavius Radu

Alexa Florina Bungau

Delia Mirela Tit

Carmen Delia Nistor Cseppento

Alexandra Georgiana Tarce

Simona Gabriela Bungau

Affiliations

Soon will be listed here.

Abstract

Adherence to prescribed medication regimens is crucial for treatment efficacy and patient safety, but it remains a challenge in the medical field, particularly in dermatology, where adherence to prescribed treatments is being intensively evaluated and improved. This narrative review provides a comprehensive overview of adherence behaviors in dermatological diseases, including fungal skin infections, psoriasis, acne, atopic dermatitis, and chronic urticaria, aiming to update scientific information on adherence patterns and management strategies in these highly prevalent conditions. Furthermore, the importance of a holistic approach that integrates patient-centered and physician-centered strategies to optimize treatment outcomes and enhance adherence in dermatological care is highlighted. The role of technological advancements in promoting adherence is also discussed, with an emphasis on the potential for digital solutions to facilitate medication management. Future perspectives underscore the need for targeted interventions to address the multifaceted barriers to adherence, including treatment complexity, healthcare accessibility, and patient-provider communication. By addressing these challenges, healthcare providers can enhance patient satisfaction, improve therapeutic outcomes, and mitigate the adverse consequences of non-adherence in dermatological practice.

Citing Articles

Copper and Zinc Levels, Prevalence of Common Variants of Genes Involved in Their Metabolism and Psoriasis Disease.

Debniak T, Baszuk P, Duchnik E, Rowinska K, Boer M, Kiedrowicz M Biomedicines. 2025; 13(2).

PMID: 40002942 PMC: 11852467. DOI: 10.3390/biomedicines13020529.

References

Lehane E, McCarthy G . Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? A discussion paper. Int J Nurs Stud. 2006; 44(8):1468-77. DOI: 10.1016/j.ijnurstu.2006.07.010. View

Kardas P, Lewek P, Matyjaszczyk M . Determinants of patient adherence: a review of systematic reviews. Front Pharmacol. 2013; 4:91. PMC: 3722478. DOI: 10.3389/fphar.2013.00091. View

Ryskina K, Goldberg E, Lott B, Hermann D, Barbieri J, Lipoff J . The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence With Acne Medications. JAMA Dermatol. 2018; 154(4):456-459. PMC: 5876856. DOI: 10.1001/jamadermatol.2017.6144. View

Torrelo A, Ortiz J, Alomar A, Ros S, Pedrosa E, Cuervo J . Health-related quality of life, patient satisfaction, and adherence to treatment in patients with moderate or severe atopic dermatitis on maintenance therapy: the CONDA-SAT study. Actas Dermosifiliogr. 2013; 104(5):409-17. DOI: 10.1016/j.adengl.2013.04.004. View

Hochsmann C, Infanger D, Klenk C, Konigstein K, Walz S, Schmidt-Trucksass A . Effectiveness of a Behavior Change Technique-Based Smartphone Game to Improve Intrinsic Motivation and Physical Activity Adherence in Patients With Type 2 Diabetes: Randomized Controlled Trial. JMIR Serious Games. 2019; 7(1):e11444. PMC: 6391647. DOI: 10.2196/11444. View

Koster E, Philbert D, Zheng X, Moradi N, De Vries T, Bouvy M . Reducing corticosteroid phobia in pharmacy staff and parents of children with atopic dermatitis. Int J Clin Pharm. 2021; 43(5):1237-1244. PMC: 8460576. DOI: 10.1007/s11096-021-01241-2. View

Yang M, Jin H, Shim W, Kim G, Kim H, Ko H . High rates of secondary non-adherence causes decreased efficacy of 0.1% topical tacrolimus in adult eczema patients: results from a multicenter clinical trial. J Dermatolog Treat. 2017; 29(2):129-134. DOI: 10.1080/09546634.2017.1350256. View

de Geest S, Sabate E . Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003; 2(4):323. DOI: 10.1016/S1474-5151(03)00091-4. View

Carrascosa J, Del-Alcazar E . Apremilast for psoriasis treatment. G Ital Dermatol Venereol. 2020; 155(4):421-433. DOI: 10.23736/S0392-0488.20.06684-5. View

10.

Carroll C, Feldman S, Camacho F, Manuel J, Balkrishnan R . Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol. 2004; 51(2):212-6. DOI: 10.1016/j.jaad.2004.01.052. View

11.

Gupta G, Mallefet P, Kress D, Sergeant A . Adherence to topical dermatological therapy: lessons from oral drug treatment. Br J Dermatol. 2009; 161(2):221-7. DOI: 10.1111/j.1365-2133.2009.09253.x. View

12.

Fouere S, Adjadj L, Pawin H . How patients experience psoriasis: results from a European survey. J Eur Acad Dermatol Venereol. 2005; 19 Suppl 3:2-6. DOI: 10.1111/j.1468-3083.2005.01329.x. View

13.

Hoffmann C, Schweighardt A, Conn K, Nelson D, Barbano R, Marshall F . Enhanced Adherence in Patients Using an Automated Home Medication Dispenser. J Healthc Qual. 2017; 40(4):194-200. DOI: 10.1097/JHQ.0000000000000097. View

14.

Kirby B, Caird A, Rogers S . Intolerance of isotretinoin in a patient with anhidrotic ectodermal dysplasia. Br J Dermatol. 1999; 141(1):175. DOI: 10.1046/j.1365-2133.1999.02954.x. View

15.

van den Bemt B, Zwikker H, van den Ende C . Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol. 2012; 8(4):337-51. DOI: 10.1586/eci.12.23. View

16.

Panahi S, Rathi N, Hurley J, Sundrud J, Lucero M, Kamimura A . Patient Adherence to Health Care Provider Recommendations and Medication among Free Clinic Patients. J Patient Exp. 2022; 9:23743735221077523. PMC: 8832560. DOI: 10.1177/23743735221077523. View

17.

Svendsen M, Andersen F, Andersen K, Andersen K . Can an app supporting psoriasis patients improve adherence to topical treatment? A single-blind randomized controlled trial. BMC Dermatol. 2018; 18(1):2. PMC: 5804085. DOI: 10.1186/s12895-018-0071-3. View

18.

Anderson K, Dothard E, Huang K, Feldman S . Frequency of Primary Nonadherence to Acne Treatment. JAMA Dermatol. 2015; 151(6):623-6. DOI: 10.1001/jamadermatol.2014.5254. View

19.

Bungau S, Tit D, Vesa C, Abid A, Szilagyi D, Radu A . Non-conventional therapeutical approaches to acne vulgaris related to its association with metabolic disorders. Eur J Pharmacol. 2022; 923:174936. DOI: 10.1016/j.ejphar.2022.174936. View

20.

Al-Hassany L, Kloosterboer S, Dierckx B, Koch B . Assessing methods of measuring medication adherence in chronically ill children-a narrative review. Patient Prefer Adherence. 2019; 13:1175-1189. PMC: 6660631. DOI: 10.2147/PPA.S200058. View